Immunovant, Inc. (IMVT) Misses Q4 EPS by 13c

Immunovant, Inc. (NASDAQ: IMVT) reported Q4 EPS of ($0.73), $0.13 worse than the analyst estimate of ($0.60).

For earnings history and earnings-related data on Immunovant, Inc. (IMVT) click here.

You May Also Be Interested In

• Etsy upgraded to buy at BofA on durable growth, buyback potential
• Twin Disc (TWIN) Tops Q4 EPS by 16c
• Sysco adds two directors, targets AI-driven cost savings of $100M